1989
DOI: 10.1164/ajrccm/140.2.397
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin 1 Production by Alveolar Macrophages Is Decreased in Smokers

Abstract: To evaluate the mechanism by which cigarette smoking suppresses pulmonary immune responses, we determined the capacity of alveolar macrophages (AM) to produce interleukin 1 (IL-1 in 32 normal subjects and in 40 patients with pulmonary sarcoidosis. The amount of IL-1 released from LPS-stimulated AM from smokers was significantly decreased compared with that in nonsmokers in both normal and sarcoid groups. The addition of indomethacin to the cultures in 18 normal subjects and in 22 patients with pulmonary sarcoi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
19
1

Year Published

1992
1992
2010
2010

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 56 publications
(23 citation statements)
references
References 13 publications
3
19
1
Order By: Relevance
“…Smoking-related differences in the proinflammatory cytokine release (IL-1β and TNF-α) shown in the studies reported so far may reflect different culture conditions or different populations [21, 22, 23, 24, 25]. In our Japanese study, the stimulation with a low concentration of LPS (1 µg/ml), the absence of serum factors, and the relatively short culture time (24 h) all partly differed from the conditions in previous studies.…”
Section: Discussionmentioning
confidence: 99%
“…Smoking-related differences in the proinflammatory cytokine release (IL-1β and TNF-α) shown in the studies reported so far may reflect different culture conditions or different populations [21, 22, 23, 24, 25]. In our Japanese study, the stimulation with a low concentration of LPS (1 µg/ml), the absence of serum factors, and the relatively short culture time (24 h) all partly differed from the conditions in previous studies.…”
Section: Discussionmentioning
confidence: 99%
“…The studies included healthy subjects, including smokers, and non-smokers (N = 19) [69-77, 79-83, 85, 86, 88, 90, 91]. Also studied were smokers with inflammatory lung disease (e.g., COPD) (N = 6) [68,78,84,87,89,90].…”
Section: Comparative Studies Of Lung Macrophages Of Current Smokers Amentioning
confidence: 99%
“…Yamaguchi [90] Cigarettes not defined MU from smokers & non-smokers TNF-a measured by ELISA The study explored the mechanisms underlying lung diseases by measuring TNF-a release by LPS-stimulated MU from smokers, non-smokers and sarcoid patients. In several reported studies, the tissue culture medium containing the smoke was passed through a micropore filter to remove tobacco smoke particulates (''tar'', N = 6) [24,41,47,49,52,54].…”
mentioning
confidence: 99%
“…17 Smoking has been shown to significantly decrease the immune response, leading to poor wound healing. In particular, smoking decreases interleukin-1 production, 18 inhibits the early signals for B-cell transduction pathways, 19 decreases cytotoxicity of natural killer cells, and causes T-cell anergy. 20 By decreasing blood flow to damaged skin, smoking increases postsurgical infections, the result of effects on the normal pathways of repair and the response to foreign contamination.…”
Section: Cutaneous Effects Of Smokingmentioning
confidence: 99%